BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34931708)

  • 1. Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.
    Milat F; Ramchand SK; Herath M; Gundara J; Harper S; Farrell S; Girgis CM; Clifton-Bligh R; Schneider HG; De Sousa SMC; Gill AJ; Serpell J; Taubman K; Christie J; Carroll RW; Miller JA; Grossmann M
    Clin Endocrinol (Oxf); 2024 Jan; 100(1):3-18. PubMed ID: 34931708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society.
    Miller JA; Gundara J; Harper S; Herath M; Ramchand SK; Farrell S; Serpell J; Taubman K; Christie J; Girgis CM; Schneider HG; Clifton-Bligh R; Gill AJ; De Sousa SMC; Carroll RW; Milat F; Grossmann M
    Clin Endocrinol (Oxf); 2021 Dec; ():. PubMed ID: 34927274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroidectomy for adults with primary hyperparathyroidism.
    Pappachan JM; Lahart IM; Viswanath AK; Borumandi F; Sodi R; Metzendorf MI; Bongaerts B
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013035. PubMed ID: 36883976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).
    Weber T; Dotzenrath C; Dralle H; Niederle B; Riss P; Holzer K; Kußmann J; Trupka A; Negele T; Kaderli R; Karakas E; Weber F; Rayes N; Zielke A; Hermann M; Wicke C; Ladurner R; Vorländer C; Waldmann J; Heizmann O; Wächter S; Schopf S; Timmermann W; Bartsch DK; Schmidmaier R; Luster M; Schmid KW; Ketteler M; Dierks C; Schabram P; Steinmüller T; Lorenz K
    Langenbecks Arch Surg; 2021 May; 406(3):571-585. PubMed ID: 33880642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperparathyroidism.
    Walker MD; Silverberg SJ
    Nat Rev Endocrinol; 2018 Feb; 14(2):115-125. PubMed ID: 28885621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperparathyroidism: new concepts, new recommendations].
    Crouzeix G; Kerlan V
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Hyperparathyroidism: Effects on Bone Health.
    Zanocco KA; Yeh MW
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperparathyroidism.
    Silva BC; Cusano NE; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Hyperparathyroidism.
    Bilezikian JP
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3993-4004. PubMed ID: 30060226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
    Lin X; Fan Y; Zhang Z; Yue H
    Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.
    Wilhelm SM; Wang TS; Ruan DT; Lee JA; Asa SL; Duh QY; Doherty GM; Herrera MF; Pasieka JL; Perrier ND; Silverberg SJ; Solórzano CC; Sturgeon C; Tublin ME; Udelsman R; Carty SE
    JAMA Surg; 2016 Oct; 151(10):959-968. PubMed ID: 27532368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of primary hyperparathyroidism with pathological fracture of the limbs: A retrospective observational study.
    Liu H; Luo K; Liao S; Tang H; Mo J; Xie T; Li C; Li B; Liu Y; Zhan X
    Medicine (Baltimore); 2022 Aug; 101(33):e29966. PubMed ID: 35984170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild primary hyperparathyroidism: a literature review.
    Applewhite MK; Schneider DF
    Oncologist; 2014 Sep; 19(9):919-29. PubMed ID: 25063228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.
    Weber TJ; Koh J; Thomas SM; Hogue JA; Scheri RP; Roman SA; Sosa JA
    Metabolism; 2017 Sep; 74():22-31. PubMed ID: 28764845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperparathyroidism - new clinical forms of the disease].
    Zajíčková K
    Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ye Z; Silverberg SJ; Sreekanta A; Tong K; Wang Y; Chang Y; Zhang M; Guyatt G; Tangamornsuksun W; Zhang Y; Manja V; Bakaa L; Couban RJ; Brandi ML; Clarke B; Khan AA; Mannstadt M; Bilezikian JP
    J Bone Miner Res; 2022 Nov; 37(11):2351-2372. PubMed ID: 36053960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asymptomatic primary hyperparathyroidism : Operation or observation?].
    Gollisch K; Siggelkow H
    Internist (Berl); 2021 May; 62(5):496-504. PubMed ID: 33710361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.
    Grossmann M; Ramchand SK; Milat F; Vincent A; Lim E; Kotowicz MA; Hicks J; Teede H
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):280-296. PubMed ID: 29741296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.